Office-Based MRI Fusion Cryoablation: Impact On PCa Treated Natural History By Recursive Partition Analysis:
Fernando J. Bianco, Giuseppe Maiolino, Edward L. Gheiler, Ariel M. Kaufman, Juan I. Martinez-Salamanca, Farshad Shafizadeh, Gloria Egui-Benatuil, and Michael Kattan
MR Fusion Cryoablation: 5 Year Outcomes For Low And Intermediate Risk Patients.
Giuseppe Maiolino, Michael Kattan, Farshad Shafizadeh, Edward L. Gheiler, Gloria Egui-Benatuil, Ariel M. Kaufman, and Fernando J. Bianco
MRI/US Fusion Guided Prostate Cryotherapy in the Office Setting under Local Anesthesia
Urological Research Network, Miami FL, USA
Urology Specialist Group, Miami Lakes, FL, USA
New York Urologic; New York, NY, USA
New England Urology, Beverly, MA
MRI/US Fusion Guided Prostate Biopsy in the Office Setting under Local Anesthesia
Urological Research Network, Miami FL, USA
Urology Specialist Group, Miami Lakes, FL, USA
New York Urologic; New York, NY, USA
New England Urology, Beverly, MA
Relevant Medical References
Hemigland Cryoablation of Clinically Significant Prostate Cancer: Intermediate-Term Followup via Magnetic Resonance Imaging Guided Biopsy. Chuang R, Kinnaird A, Kwan L, Sisk A, Barsa D, Felker E, Delfin M, Marks L. J Urol. 2020 Nov;204(5):941-949. doi: 10.1097/JU.0000000000001133. Epub 2020 Sep 28.PMID: 32985924
Editorial Comment. Bianco FJ. J Urol. 2020 Nov;204(5):948-949. doi: 10.1097/JU.0000000000001133.01. .PMID: 32985926
Eldred-Evans D, Neves JB, Simmons LAM, Kanthabalan A, McCartan N, Shah TT, Arya M, Charman SC, Freeman A, Moore CM, Punwani S, Emberton M, Ahmed HU. BJU Int. 2020 Mar;125(3):391-398. doi: 10.1111/bju.14953.PMID: 31733173
SPARED Collaboration: Patient Selection for Partial Gland Ablation in Men with Localized Prostate Cancer. Gross MD, Sedrakyan A, Bianco FJ, Carroll PR, Daskivich TJ, Eggener SE, Ehdaie B, Fisher B, Gorin MA, Hunt B, Jiang H, Klein EA, Marinac-Dabic D, Montgomery JS, Polascik TJ, Priester AM, Rastinehad AR, Viviano CJ, Wysock JS, Hu JC.J Urol. 2019 Nov;202(5):952-958. doi: 10.1097/JU.0000000000000357. PMID: 3114459
Super active surveillance for low-risk prostate cancer | Opinion: Yes. Reis LO, Andrade DL, Bianco FJ. Int Braz J Urol. 2019 Mar-Apr;45(2):210-214. doi: 10.1590/S1677-5538.IBJU.2019.02.02.PMID: 31021584
Accuracy of Transperineal Targeted Prostate Biopsies, Visual Estimation and Image Fusion in Men Needing Repeat Biopsy in the PICTURE Trial. Simmons LAM, Kanthabalan A, Arya M, Briggs T, Barratt D, Charman SC, Freeman A, Hawkes D, Hu Y, Jameson C, McCartan N, Moore CM, Punwani S, van der Muelen J, Emberton M, Ahmed HU. J Urol. 2018 Dec;200(6):1227-1234. doi: 10.1016/j.juro.2018.07.001.PMID: 30017964
The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsy. Simmons LAM, Kanthabalan A, Arya M, Briggs T, Barratt D, Charman SC, Freeman A, Gelister J, Hawkes D, Hu Y, Jameson C, McCartan N, Moore CM, Punwani S, Ramachandran N, van der Meulen J, Emberton M, Ahmed HU.Br J Cancer. 2017 Apr 25;116(9):1159-1165. doi: 10.1038/bjc.2017.57.PMID: 28350785
Bianco FJ, Martínez-Salamanca JI. Arch Esp Urol. 2016 Jul;69(6):353-63.
Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N, Okoro C, Raskolnikov D, Parnes HL, Linehan WM, Merino MJ, Simon RM, Choyke PL, Wood BJ, Pinto PA. JAMA. 2015 Jan 27;313(4):390-7. doi: 10.1001/jama.2014.17942.PMID: 25626035